Refile: TABLE-Sawai Pharmaceutical - 6-MTH group results

SAWAI group

13/11/2017 06:49

(Adds company forecast. Accounting policy for forecast is IFRS) 
Nov 13 (Reuters)-  
Sawai Pharmaceutical Co Ltd  
CONSOLIDATED FINANCIAL HIGHLIGHTS 
(in billions of yen unless specified) 
 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2017        Sep 30, 2016     Mar 31, 2018 
                     LATEST             YEAR-AGO          LATEST 
                     RESULTS             RESULTS         FORECAST 
  Sales               70.76               65.42            168.80 
                   (+8.2 pct)          (+11.0 pct) 
  Operating           11.14               11.36             23.70 
                   (-1.9 pct)          (-2.1 pct) 
  Recurring           11.80               11.33             23.30 
                   (+4.2 pct)          (-1.0 pct) 
  Net                  8.79                8.57             17.30 
                   (+2.6 pct)          (+0.8 pct) 
  EPS              238.45 yen          232.33 yen       469.22 yen 
  EPS Diluted      238.30 yen          232.20 yen 
  Ann Div                              130.00 yen       130.00 yen 
  -Q2 div           65.00 yen           65.00 yen 
  -Q4 div                               65.00 yen        65.00 yen 
    
NOTE - Sawai Pharmaceutical Co Ltd. 
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T ((Tokyo 
Headline News Desk +813 6441 1812))